vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and ST JOE Co (JOE). Click either name above to swap in a different company.

Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $128.9M, roughly 1.3× ST JOE Co). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 23.5%). Over the past eight quarters, ST JOE Co's revenue compounded faster (21.2% CAGR vs 10.6%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

The St. Joe Company is a land development company headquartered in Panama City Beach, Florida. Founded in 1936 and until 1966 known as St. Joe Paper Company, the company still operates a forestry division but is primarily engaged in real estate development and asset management. The company's land holdings are concentrated in Northwest Florida with the vast majority located in Bay and Walton counties. Of the 110,500 acres The St. Joe Company owns that fall within the Bay-Walton Sector Plan, 53...

ESPR vs JOE — Head-to-Head

Bigger by revenue
ESPR
ESPR
1.3× larger
ESPR
$168.4M
$128.9M
JOE
Growing faster (revenue YoY)
ESPR
ESPR
+120.2% gap
ESPR
143.7%
23.5%
JOE
Faster 2-yr revenue CAGR
JOE
JOE
Annualised
JOE
21.2%
10.6%
ESPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESPR
ESPR
JOE
JOE
Revenue
$168.4M
$128.9M
Net Profit
$29.9M
Gross Margin
45.4%
Operating Margin
50.6%
30.6%
Net Margin
23.2%
Revenue YoY
143.7%
23.5%
Net Profit YoY
58.2%
EPS (diluted)
$0.32
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
JOE
JOE
Q4 25
$168.4M
$128.9M
Q3 25
$87.3M
$161.1M
Q2 25
$82.4M
$129.1M
Q1 25
$65.0M
$94.2M
Q4 24
$69.1M
$104.3M
Q3 24
$51.6M
$99.0M
Q2 24
$73.8M
$111.6M
Q1 24
$137.7M
$87.8M
Net Profit
ESPR
ESPR
JOE
JOE
Q4 25
$29.9M
Q3 25
$-31.3M
$38.7M
Q2 25
$-12.7M
$29.5M
Q1 25
$-40.5M
$17.5M
Q4 24
$18.9M
Q3 24
$-29.5M
$16.8M
Q2 24
$-61.9M
$24.5M
Q1 24
$61.0M
$13.9M
Gross Margin
ESPR
ESPR
JOE
JOE
Q4 25
45.4%
Q3 25
44.4%
Q2 25
42.9%
Q1 25
37.8%
Q4 24
42.3%
Q3 24
39.4%
Q2 24
44.6%
Q1 24
39.0%
Operating Margin
ESPR
ESPR
JOE
JOE
Q4 25
50.6%
30.6%
Q3 25
-11.4%
32.9%
Q2 25
8.6%
28.6%
Q1 25
-34.0%
17.9%
Q4 24
-6.4%
24.7%
Q3 24
-31.0%
21.5%
Q2 24
3.5%
29.2%
Q1 24
52.5%
18.2%
Net Margin
ESPR
ESPR
JOE
JOE
Q4 25
23.2%
Q3 25
-35.9%
24.0%
Q2 25
-15.4%
22.9%
Q1 25
-62.2%
18.5%
Q4 24
18.1%
Q3 24
-57.2%
17.0%
Q2 24
-83.9%
22.0%
Q1 24
44.3%
15.9%
EPS (diluted)
ESPR
ESPR
JOE
JOE
Q4 25
$0.32
$0.51
Q3 25
$-0.16
$0.67
Q2 25
$-0.06
$0.51
Q1 25
$-0.21
$0.30
Q4 24
$-0.14
$0.32
Q3 24
$-0.15
$0.29
Q2 24
$-0.33
$0.42
Q1 24
$0.34
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
JOE
JOE
Cash + ST InvestmentsLiquidity on hand
$167.9M
$129.6M
Total DebtLower is stronger
$391.2M
Stockholders' EquityBook value
$-302.0M
$766.3M
Total Assets
$465.9M
$1.5B
Debt / EquityLower = less leverage
0.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
JOE
JOE
Q4 25
$167.9M
$129.6M
Q3 25
$92.4M
$126.1M
Q2 25
$86.1M
$88.2M
Q1 25
$114.6M
$94.5M
Q4 24
$144.8M
$88.8M
Q3 24
$144.7M
$82.7M
Q2 24
$189.3M
$86.7M
Q1 24
$226.6M
$89.8M
Total Debt
ESPR
ESPR
JOE
JOE
Q4 25
$391.2M
Q3 25
$399.0M
Q2 25
$427.3M
Q1 25
$434.8M
Q4 24
$437.8M
Q3 24
$443.3M
Q2 24
$447.4M
Q1 24
$452.0M
Stockholders' Equity
ESPR
ESPR
JOE
JOE
Q4 25
$-302.0M
$766.3M
Q3 25
$-451.4M
$760.7M
Q2 25
$-433.5M
$738.8M
Q1 25
$-426.2M
$727.9M
Q4 24
$-388.7M
$724.3M
Q3 24
$-370.2M
$716.4M
Q2 24
$-344.2M
$708.1M
Q1 24
$-294.3M
$690.4M
Total Assets
ESPR
ESPR
JOE
JOE
Q4 25
$465.9M
$1.5B
Q3 25
$364.0M
$1.5B
Q2 25
$347.1M
$1.5B
Q1 25
$324.0M
$1.5B
Q4 24
$343.8M
$1.5B
Q3 24
$314.1M
$1.5B
Q2 24
$352.3M
$1.6B
Q1 24
$373.1M
$1.5B
Debt / Equity
ESPR
ESPR
JOE
JOE
Q4 25
0.51×
Q3 25
0.52×
Q2 25
0.58×
Q1 25
0.60×
Q4 24
0.60×
Q3 24
0.62×
Q2 24
0.63×
Q1 24
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
JOE
JOE
Operating Cash FlowLast quarter
$45.2M
$190.7M
Free Cash FlowOCF − Capex
$186.6M
FCF MarginFCF / Revenue
144.8%
Capex IntensityCapex / Revenue
0.0%
3.1%
Cash ConversionOCF / Net Profit
6.37×
TTM Free Cash FlowTrailing 4 quarters
$329.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
JOE
JOE
Q4 25
$45.2M
$190.7M
Q3 25
$-4.3M
$86.2M
Q2 25
$-31.4M
$31.1M
Q1 25
$-22.6M
$29.0M
Q4 24
$-35.0M
$108.0M
Q3 24
$-35.3M
$27.7M
Q2 24
$-7.2M
$22.8M
Q1 24
$53.8M
$27.6M
Free Cash Flow
ESPR
ESPR
JOE
JOE
Q4 25
$186.6M
Q3 25
$85.2M
Q2 25
$29.7M
Q1 25
$27.8M
Q4 24
$100.2M
Q3 24
$-35.5M
$25.9M
Q2 24
$-7.3M
$21.5M
Q1 24
$53.8M
$25.2M
FCF Margin
ESPR
ESPR
JOE
JOE
Q4 25
144.8%
Q3 25
52.9%
Q2 25
23.0%
Q1 25
29.6%
Q4 24
96.1%
Q3 24
-68.7%
26.2%
Q2 24
-9.9%
19.3%
Q1 24
39.0%
28.7%
Capex Intensity
ESPR
ESPR
JOE
JOE
Q4 25
0.0%
3.1%
Q3 25
0.0%
0.6%
Q2 25
0.0%
1.0%
Q1 25
0.0%
1.2%
Q4 24
0.0%
7.4%
Q3 24
0.3%
1.8%
Q2 24
0.1%
1.2%
Q1 24
0.1%
2.7%
Cash Conversion
ESPR
ESPR
JOE
JOE
Q4 25
6.37×
Q3 25
2.23×
Q2 25
1.05×
Q1 25
1.66×
Q4 24
5.71×
Q3 24
1.65×
Q2 24
0.93×
Q1 24
0.88×
1.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

JOE
JOE

Residential Real Estate Segment$57.2M44%
Hospitality Segment$47.4M37%
Commercial$20.5M16%
Sjbb Llc$2.8M2%

Related Comparisons